Grace Therapeutics GRCE
NASDAQ GRCE
$1.92 -0.05 (-2.55%)
As of: Oct 22, 2026 · 9:51 AM EDT

Grace Therapeutics (GRCE) Invested Capital (2019)

Updated

Grace Therapeutics (GRCE) posted Invested Capital of $11.86 million for fiscal Q4 2019 (quarter ended Mar 31, 2019).

Analysis

Grace Therapeutics (GRCE) Invested Capital (2019) Analysis & Trends

For FY2019 (ended Mar 31, 2019), Grace Therapeutics' Invested Capital came in at $12.41 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Eli Lilly 1,148.13 Bn 1,116.72 Bn 19.71 Bn 88.79 Bn
2 Johnson & Johnson 630.09 Bn 548.62 Bn 17.26 Bn 134.01 Bn
3 AbbVie 498.99 Bn 472.10 Bn 12.70 Bn 64.89 Bn
4 Merck 374.92 Bn 329.30 Bn 12.21 Bn 95.89 Bn
5 Novartis Ag 300.99 Bn 264.98 Bn 11.24 Bn 51.53 Bn
6 Astrazeneca 264.63 Bn 238.32 Bn 12.86 Bn 82.72 Bn
7 Amgen 239.15 Bn 194.55 Bn 7.24 Bn 68.99 Bn
8 Gilead Sciences 192.23 Bn 166.43 Bn 6.22 Bn 38.08 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 148.69 Bn
10 Grace Therapeutics 33.04 Mn -33.23 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2019 11.76 Mn
API Access

Grace Therapeutics Invested Capital API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=invested-capital&ticker=GRCE&period=max&api_key=YOUR_API_KEY